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Edited by Richard CogdellAbstract A recombinant DING protein from Pseudomonas ﬂu-
orescens has been previously shown to have a phosphate-binding
site, and to be mitogenic for human cells. Here we report the
three-dimensional structure of the protein, conﬁrming a close
similarity to the ‘‘Venus ﬂytrap’’ structure seen in other human
and bacterial phosphate-binding proteins. Site-directed mutagen-
esis conﬁrms the role of a key residue involved in phosphate bind-
ing, and that the mitogenic activity is not dependent on this
property. Deletion of one of the two hinged domains that consti-
tute the Venus ﬂytrap also eliminates phosphate binding whilst
enhancing mitogenic activity.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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DING proteins were identiﬁed in a wide range of eukaryotic
organisms, on the basis of conserved DINGGG N-terminal
amino acid sequences [1,2]. Despite much eﬀort, no complete
gene sequences are known for these proteins, and only a single
complete amino acid sequence. The latter was determined from
the X-ray crystallographic structure determination of a human
phosphate-binding protein (HPBP), puriﬁed from the high-
density lipoprotein fraction of plasma, and conﬁrmed by mass
spectrometric peptide sequencing [3–6].
The tertiary structure of HPBP conﬁrms the ability of this
protein to bind a single phosphate ion, in the same manner
as the bacterial pstS proteins, which sequester phosphate for
cellular uptake by the ABC phosphate transporter. The pstS
and the HPBP structures ﬁt a model known as the ‘‘Venus ﬂy-
trap’’, in which two globular domains hinge together to form
the phosphate-binding site, with eight conserved residues H-
bonding to phosphate [5,7,8].
Partial gene and protein sequences are also known for sev-
eral plant DING proteins [1,2], one of which was isolated*Corresponding author. Fax: +64 9 3737 668.
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doi:10.1016/j.febslet.2007.06.050and clon\ed from St. John’s Wort (Hypericum perforatum) on
the basis of anti-HIV activity in lymphocytes. This p27SJ pro-
tein is clearly homologous to existing DING sequences [2], but
is C-terminally truncated, possibly as a result of proteolysis by
coagulation factor Xa action during the preparation of plant
extracts [9]. In the p27SJ protein, all of the phosphate-binding
residues are conserved, but it is not known if the protein binds
a phosphate ion.
PstS proteins are ubiquitous in bacteria, but some Pseudomo-
nas genomes contain geneswhich aremuchmore homologous to
the eukaryoticDINGproteins. These genes form two families of
phosphate-binding proteins, which may be involved in phos-
phate scavenging [2]. One such gene, from P. ﬂuorescens, has
been cloned and expressed [10]. The resulting protein (PﬂuD-
ING) has a single phosphate-binding site. It also possessesmito-
genic activity towards human ﬁbroblasts, which is consistent
with similar activity ascribed to human DING proteins [11–
14]. In stimulating DNA synthesis, the bacterial DING protein
does not stimulate cellular phosphate uptake [10]. The PﬂuD-
ING sequence most closely resembles that of p27SJ (Fig. 1).
Because there are no complete DING gene sequences from
eukaryotes, PﬂuDING oﬀers the most convenient model for
pursuing structure–function relationships in DING proteins.
We here describe experiments to establish the tertiary structure
of the PﬂuDING protein, and to investigate further the phos-
phate-binding role in relation to mitogenic activity.2. Methods
A recombinant PﬂuDING protein was expressed in E. coli BL21
(DE3) as a fusion protein with a C-terminal hexahistidine tag, coded
in the pET22b(+) plasmid vector, and puriﬁed from bacterial lysates
by aﬃnity chromatography, as previously described [10].
Crystallization of PﬂuDING was performed using the hanging drop
vapor diﬀusion method and by mixing the reservoir solution composed
of 25% (w/v) PEG 8000, 100 mM acetate buﬀer pH 4.5 and 200 mM
Li2SO4 with a PﬂuDING solution at 10 mg/mL. A single dataset was
collected at the BM14 UK MAD beamline (ESRF, Grenoble, France)
at a wavelength of 0.953 A˚. Crystallization and data collection are fur-
ther described in Moniot et al., 2007 [15]. Statistics of the dataset are
summarized in Table 1.
The initial phase was obtained using the molecular replacement
method with the MOLREP program [16]. Since the PﬂuDING amino
acid sequence displays 71% identity with the HPBP sequence, HPBP
structure was used as a starting model (PDB code 2CAP). The PﬂuD-
ING model was built through reﬁnement and manual building cycles
using REFMAC5 [17] and Coot [18]. The ﬁnal model shows R and
Rfree factor values of 13.1% and 16.4%, respectively (Table 1). Coordi-
nates and associate structure factor ﬁles have been deposited within the
Protein Data Bank (ID code 2Q9T). Figs. 2–5 were drawn with Py-
MOL (http://www.pymol.org).blished by Elsevier B.V. All rights reserved.
PfluDING    DINGGGATLPQALYQTSGVLTAGFAQYIGVGSGNGKAAFLNNDYTKFQAGVTNKNVHWAGSDSKLSA
HPBP        DINGGGATLPQKLYLTPDVLTAGFAPYIGVGSGKGKIAFLENKYNQFG-TDTTKNVHWAGSDSKLTA
HypDING   MADINGGGATLPQALYQTSGVLTAGFAPYIGVGSGNGKAAFLNNDYTKFQAGVTNKNVHWAGSDSKLSA
PfluDING    TELSTYASAKQPTWGKLIQVPSVGTSVAIPFNKSGSAAVDLSVQELCGVFSGRINTWDGISGSGRTG
HPBP        TELATYAADKEPGWGKLIQVPSVATSVAIPFRKAGANAVDLSVKELCGVFSGRIADWSGITGAGRSG
HypDING     TELSTYASAKQPTWGKLIQVPSVGTAVAIPFNKSGTAAVDLSVSELCGVFSGRITDWSGISGSGRTG
PfluDING    PIVVVYRSESSGTTELFTRFLNAKCNAETGNFAVTTTFGTSFSGGL--PAGAVAATGSQGVMTALAA
HPBP        PIQVVYRAESSGTTELFTRFLNAKCTTQPGTFAVTTVFANSYSLGLSPLAGAVAAIGSVGVMAADND
HypDING     AITVVYRSESSGTTELFTRFLNAKC-AETGTFNISTTFGTSYTGGL--PAGAVSAAGSQGVMTALAG
PfluDING    G---DGRITYMSPDFAAPTLAGLDDATKVARVGKNVA--TNTQGVSPAAANVSAAIGAVPVPAAADR
HPBP        VTTAQGRITYISPDFAAPTLAGLDDATKVARTGKGSSSGGGAEGKSPAAANVSAAISVVPLPAAADR
HypDING   A---DGGTTYMSPDFAAPTLAGLDDATKVARVGKDVA--TNTAGVSPAAANVSAAINAVPVPASTEK
PfluDING    SNPDAWVPVFGPDNTAGVQPYPTSGYPILGFTNLIFSQCYADATQTTQVRDFFTKHYGASNNNDAAI
HPBP        GDPNVWTPVFGAVTGGGVVAYPDSGYPILGFTDLIFSECYANATQTGQVRNFFTKHYGTSANDNAAI
HypDING     P------------------------------------------------------------------
PfluDING    TANAFVPLPTAWKATVRASFLTASNALSIGNTNVCNGIGRPLLE
HPBP        QANAFVPLPSNWKAAVRASYLTASNALSIGDSAVCGGKGRPE 
HypDING     ------------------------------------------   
Fig. 1. Alignment of the amino acid sequences of three DING proteins. PﬂuDING: the recombinant PﬂuDING protein sequence. HPBP: human
plasma phosphate-binding protein sequence. HypDING: Hypericum perforatumDING protein sequence, p27SJ. Matches in blue, with the conserved
residues involved in phosphate binding bold and underlined. Sequences are aligned with reference to the structural superposition of the PﬂuDING
and HPBP ternary structures.
Table 1
Dataset and reﬁnement statistics
Data collection
Wavelength (A˚) 0.9535
Resolution (last bin) (A˚) 62–1.43 (1.50–1.43)
Space group P21
Unit cell (A˚) a = 36.7, b = 123.7, c = 40.8,
a = 90.0, b = 116.7, c = 90.0
Observed reﬂections (last bin) 235730 (21073)
Unique reﬂection (last bin) 58905 (7166)
Completeness (last bin) (%) 98.1 (89.2)
Rsym (last bin) (%) 2.6 (10.2)
Mean I/r(I) (last bin) 38.9 (10.5)
Reﬁnement statistics
Resolution range (A˚) 61.90–1.43
Rwork/Rfree 13.1/16.4
Number of protein atoms 3743
Number of water molecules 766
Average B factor (A˚2) 10.15
Rms bond length (A˚) 0.007
Rms bond angle () 1.119
Rwork ¼
P
F oF cP
F o
, where Fo denotes the observed structure factor
amplitude and Fc denotes the structure factor amplitude calculated
from the model, Rfree is as for Rwork, but it is calculated with 5% of
randomly chosen reﬂections omitted from the reﬁnement.
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were explored, using the Psipred software [19]. A mutated protein with
a T147N substitution was created by overlap extension PCR [20] with
PﬂuDING cDNA as the starting template, using the following primers
(forward SAD1: 5 0GC GAA AGC AGT GGT AAC ACT GAG CTG
TTC, reverse SAD2: 5 0GAA CAG CTC AGT GTT ACC ACT GCT
TTC GC) in conjunction with the forward and reverse primers origi-
nally used to amplify the PﬂuDING coding sequence (MD5 and
MD6), and using the same conditions for the PCR reaction [10]. Fol-
lowing a sequence check of the mutated cDNA, restriction, ligation
and cloning into the pEt22b+ plasmid were carried out as before [10].
To create the truncated version of PﬂuDING, the primers NT1 (5 0
CAA CCA TGG TGG GGA CTT CGG TTG CC) and CT2 (5 0
CGT CTC GAG TGC GCC GAT AGC GGC AGA CAC) were cre-
ated, and used for PCR with the normal PﬂuDING cDNA as tem-plate. NT1 causes truncation immediately before the codon CTG,
corresponding to V90 in PﬂuDING, and CT2 caused truncation imme-
diately after the codon GCA, for A252. The resulting cDNA was of
about 500 bps, corresponding to the predicted size of 506 bps, and
had the correct nucleotide sequence. The primers contained restriction
sites for NcoI and XhoI, respectively, so the cDNA was restricted, li-
gated and cloned into the pET22b(+) plasmid, as for other PﬂuDING
preparations. Both mutated PﬂuDING derivatives were expressed and
puriﬁed as for the normal protein.
Western blotting was carried out with a rabbit antiserum to a con-
jugated human DING protein N-terminal peptide, as previously de-
scribed [13]. Double immunodiﬀusion was carried out with a rabbit
antiserum prepared against puriﬁed recombinant PﬂuDING, using
standard immunization protocols.
Filter-binding assays for 32P-phosphate binding to DING proteins,
and mitogenic assays, based on incorporation of 3H-thymidine, were
also carried out as before [10]. For the phosphate-binding experiments,
3.6 lg of each protein was used, in triplicate assays. Diﬀering concen-
trations of each protein (0.6–3.0 lM) were added to cell cultures for
mitogenic assays.3. Results and discussion
The three-dimensional model of PﬂuDING reveals an elon-
gated fold composed of two adjacent globular domains. Each
domain is constituted by a central b-sheet core ﬂanked by a-
helices and contains a disulﬁde bridge (C114–C159 and
C300–C363). Interconnected by an antiparallel two-stranded
b-sheet acting as a hinge, the two domains form a deep cleft
wherein is bound a phosphate molecule. This fold, known as
a Venus ﬂytrap, is very similar to those of the sixth family of
solute binding proteins (SBP) [21,22]. Structural superposition
(Fig. 2) shows good correspondence between our model and
the structures of E. coli phosphate-binding protein (pdb code
1IXH) and HPBP (pdb code 2CAP), with root mean square
deviations (rmsd) of 1.881 A˚ on 276 Ca atoms and 0.649 A˚
on 366 Ca atoms, respectively. Similar to the eukaryotic HPBP
[5], the PﬂuDING structure exhibits four protruding loops
when compared with the E. coli binding protein. Though these
loops are a little shorter, they superimpose almost perfectly
Fig. 2. Ternary structure superposition. (left) The overall structure of the DING protein from Pseudomonas ﬂuorescens is shown in cartoon mode.
The two domains of the protein are colored in blue and green and the hinge is presented in yellow. Both disulﬁde bridges are presented in orange. The
phosphate molecule is represented in ball and stick mode (in red). (middle) Structural comparison between the P. ﬂuorescens DING protein (in
yellow) and the human phosphate-binding protein (HPBP) (pdb code 2CAP) (in green). (right) Structural comparison between the P. ﬂuorescens
DING protein (in yellow) and the phosphate-binding protein from Escherichia coli (pdb code 1IXH) (in purple). The phosphate from the PﬂuDING
structure is represented in ball and stick mode (in red). Protruding loops of PﬂuDING and HPBP are indicated by arrows.
Fig. 3. Views of the phosphate-binding site. Residues involved in the binding of the phosphate molecule are labeled. The 12 H-bonds between the
protein and the phosphate molecule are represented in dashed lines. Side chains are shown in sticks and main chain is represented in cartoon mode.
(A) The 2Fo  Fc map calculated omitting the phosphate molecule was contoured at 5r. Hydrogen bond distances are indicated in A˚. (B) Binding site
cavity. Surface is compute from the protein Van der Waals surface using a 1.6 A˚ probe sphere radius.
S. Ahn et al. / FEBS Letters 581 (2007) 3455–3460 3457with those of HPBP (Fig. 2). Structural comparison thus re-
veals that PﬂuDING superimposes more closely on HPBP,
and possesses similar protruding loops. This strongly supports
the hypothesis deduced from the high sequence identity be-
tween both proteins (71%) that bacterial PﬂuDING is closely
related to the eukaryotic DING protein family [2].
The binding site of PﬂuDING, located between the two do-
mains, is totally buried and sequesters a phosphate molecule
that copuriﬁed with the protein. The phosphate is tightly
bound by 12 hydrogen bonds formed with 8 residues distrib-uted on either side of the cleft (Fig. 3). Residues implicated
in phosphate binding are T8, L9, S32, D62, R141, S145,
G146 and T147. Hydrogen bonds distances range from 2.49
to 3.16 A˚. The shortest hydrogen bond involves a phosphorus
oxygen atom and a carboxylic oxygen from the D62 side chain.
Such short bonds have also been reported in E. coli pstS
(1IXH), M. tuberculosis pstS-1 (1PC3), and HPBP (2CAP)
structures with distances as small as 2.43 A˚. Being potentially
the only hydrogen bond acceptor in the binding site cavity of
PﬂuDING, D62 should play a key role in phosphate speciﬁcity
Fig. 4. The Venus ‘‘ﬂytrap’’ motion. The bending motion of the Venus
‘‘ﬂytrap’’ fold is presented through comparison of ‘‘closed’’ (wild-type)
(in purple) and ‘‘open’’ (T141D mutant) (in blue) forms of E. coli PBP
(pdb code 1OIB and 1IXH). Both proteins are presented in a cartoon
mode with their corresponding molecular surface. The inorganic
phosphate bound in the closed form is represented as balls and sticks
(red).
3458 S. Ahn et al. / FEBS Letters 581 (2007) 3455–3460by accepting protonated phosphate species [7]. The binding
sites residues are completely identical to those identiﬁed in
the HPBP structure.
Previous studies have shown that PﬂuDING bound 32P-
phosphate, corresponding to approximately one mole of phos-
phate per mole of protein, with a KD of 1.7 lM [10]. The KD
values for the E. coli and P. aeruginosa pstS proteins are
approximately 1 lM and 0.34 lM, respectively [7,23]. It isFig. 5. N- and C-terminal truncation. (A) C-terminal truncated form (As
(truncated part is shown as transparent). (B) N- and C-terminal truncated
PAGE of standard protein markers (lane M), wild-type PﬂuDING (lane DInot immediately obvious from the structural comparisons
why the PﬂuDING and pstS proteins should have diﬀerent
aﬃnities for phosphate.
The ‘‘Venus ﬂytrap’’ fold was shown to undergo large con-
formational changes upon ligand binding. These structures
were shown to adopt a ‘‘closed’’ conformation whilst ligand
is bound, and an ‘‘open’’ conformation without ligand,
through a bending motion of the two domains around the
hinge [22]. Yao et al. obtained a T141D mutant of E coli pstS
(equivalent to a T147 substitution in PﬂuDING) with a re-
duced phosphate aﬃnity [24,25]. From this mutant it was pos-
sible to obtain both ‘‘closed’’ and ‘‘open’’ forms of this protein
(Fig. 4).
With the aim of obtaining similar properties, the T147N
PﬂuDING mutant was prepared, successfully expressed and
puriﬁed. The normal PﬂuDING protein (3.6 lg) bound
3.3 · 104 (±0.2 · 104) dpm of the radioisotopic phosphate,
whereas in the same quantity of the PﬂuDING T147N mutant
protein, phosphate binding was reduced by 85%, to 0.5 · 104
(±0.05 · 104) dpm.
Another putative mutant version of PﬂuDING was created,
with the substitutions R141L, S145I and T147I. Although ex-
pressed in our E. coli system, the resulting protein was almost
entirely insoluble (not shown).
Truncation of PﬂuDING was considered because of the dis-
covery of the biologically-active DING protein from H. perfo-
ratum, which comprises 263 residues with 89% sequence
identity with the N-terminal sequence of the PﬂuDING pro-
tein (see Fig. 1). Though the nature of the activity (inhibition
of gene expression and replication in HIV-infected cells [7])
is very diﬀerent from those observed with most other DING
proteins, we thought it possible that such proteins might retain
other activities if similarly truncated. Accordingly, we designedp1–Arg261) deduced from the complete structure of the PﬂuDING
form (Val90–Ala252) deduced from the complete structure. (C) SDS–
NG) and the N- and C-terminally truncated mutant (lane NCTD).
S. Ahn et al. / FEBS Letters 581 (2007) 3455–3460 3459a primer to amplify PﬂuDING cDNA, in conjunction with
MD5, between the N-terminal codon and the codon for
R261. Although the corresponding cloned, truncated protein
could be readily expressed, only traces of the expected
27 kDa protein were seen, with much larger quantities of 25,
23 and 20 kDa proteins, corresponding to products of N-ter-
minal proteolysis (not shown). It is clear from the structure
(Fig. 5A) that the deletion of the C-terminal part of the ‘‘lower
lobe’’ of the ‘‘Venus ﬂytrap’’ could expose the remainder of the
structure to proteolysis, either during bacterial protein pro-
cessing, or during bacterial lysis and protein puriﬁcation. We
therefore resolved to remove the proteolytically-sensitive re-
gion by genetic truncation. Consideration of the structure of
PﬂuDING suggested that a concomitant extension of the C-
terminal truncation would eﬀectively create a 17 kDa protein
comprising just the ‘‘upper lobe’’ of the complete PﬂuDING
(Fig. 5B). Thus, primers were designed to amplify the PﬂuD-
ING coding sequence from the V90 codon to that for A252.
The details of the production of this NCTD protein are sum-
marized in Fig. 5C. It has a molecular weight of 17 kDa, as ex-
pected from the genetic truncation. It retains a partial
immunological cross-reaction with the native PﬂuDING, but
cannot be detected in Western blots with an antiserum speciﬁc
for the DING N-terminus (not shown). When used in phos-
phate-binding experiments, the extent of binding was reduced
by over 92%, compared to native PﬂuDING (0.3 · 104
(±0.2 · 104) dpm for the truncated mutant, compared to
3.3 · 104 (±0.2 · 104) dpm for the native protein). This is
unsurprising, given that four of the eight phosphate-coordinat-
ing residues (T8, L9, S32 and D62) have been eliminated, to-
gether with one side of the phosphate-binding cleft.
The mitogenic activity of the two mutants was compared
with the native protein (Table 2). We have previously shown
that PﬂuDING is mitogenic for human ﬁbroblasts, albeit
much less eﬃciently than is a DING protein secreted by these
cells [10,12,13]. Here we show that, in the absence of bound
phosphate, the protein not only retains mitogenic activity,
but the activity is enhanced. This observation may indicate
that the DING protein has to be in an ‘‘open’’ conformation
for mitogenic activity, and that the ‘‘closing of the ﬂytrap’’,
which accompanies phosphate binding, may reduce this activ-
ity. A similar phenomenon occurs when one domain of the
protein is absent, indicating that the ‘‘upper’’ domain, V90-
A252, contains a site for mitogenic signalling. Further work
is clearly needed to elucidate this eﬀect, but the availability
of the NCTD mutant should make it easier to identify the siteTable 2
Relative stimulation of thymidine incorporation in human ﬁbroblasts
by native and mutated PﬂuDING
Reagent Incorporation of 3H
thymidine (dpm · 103)
Relative
incorporation (%)
3% FCS 1.2 (±0.4) 100
PﬂuDING
0.63 lM 1.0 (±0.3) 83
1.3 lM 2.3 (±0.2) 192
T147N
0.63 lM 5.5 (±0.4) 458
1.3 lM 6.4 (±0.4) 533
Trunc.
1.5 lM 7.3 (±0.6) 608
3.0 lM 8.2 (±0.2) 683responsible for mitogenic activity. X-ray structures of both the
T147N mutant, possibly in an ‘‘open’’ conformation, and the
NCTD mutant should also be of great interest in helping to
understand the molecular mechanism of modulation of mito-
genic activity.
We previously showed that organophosphates would also
bind to the phosphate-binding site in PﬂuDING [10]. In partic-
ular, ADP appeared to be an eﬀective competitive inhibitor for
phosphate binding. Sphingosine 1-phosphate was tested as a
putative inhibitor, as this reagent has been shown to function
as both an intracellular or extracellular component of signal-
ling systems [26]. However, at concentrations of 0.1 and
1 mM, sphingosine 1-phosphate had essentially no eﬀect on
phosphate binding to the PﬂuDING protein. Other bioactive
organophosphates, nucleotides and phospholipids are obvious
candidates for future investigation in this regard.
The PﬂuDING structure (Figs. 2 and 3) reveals that the
bound phosphate ion almost ﬁlls the buried cavity. To illus-
trate, the nearest crystallographic solvent molecules are situ-
ated 6 A˚ away from the phosphate. Accommodation of any
larger phosphate metabolites would require conformational
changes, presumably in accordance with the ‘‘Venus ﬂytrap’’
motion. Organophosphate binding should thus induce a par-
tial opening of the cleft, but it is not yet clear what eﬀect this
will have upon the mitogenic activity of the protein.
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